MoneyWorks4Me

Divi’s Laboratories informs about earnings conference call

03 Feb 2022 Evaluate

Further to its intimations dated January 28, 2022 and February 01, 2022, Divi’s Laboratories has informed that the earnings conference call for Q3FY22 has been rescheduled to February 11, 2022. Details of the revised earnings conference call is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..